Intravitreous bevacizumab adult safety data: the evidence so far

Clin Exp Ophthalmol. 2012 Jan-Feb;40(1):3-5. doi: 10.1111/j.1442-9071.2011.02739.x.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects*
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Bevacizumab
  • Humans
  • Intravitreal Injections
  • Macular Degeneration / drug therapy
  • Off-Label Use
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab